Investigators

Director/Associate Director

Principal Investigator: Jennifer Rubin Grandis, MD

Co-Principal Investigator: Eugene N. Myers, MD

Principal Investigators, Research Projects:

Project 1: Cyclin D1 and XPD Polymorphisms as Potential Risk Factors for SCCHN

Marjorie Romkes, PhD, Joel Weissfeld, MD, MPH

Project 2: Therapeutic Inhibition of the Stat3-to Bcl-XL Signaling Axis in SCCGN

Jennifer R. Grandis, MD, William C. Zamboni, PharMD

Project 3: Wild Type P53-Based Adjuvant Immunotherapy for SCCHN

Albert DeLeo, PhD, Robert Ferris, MD, PhD

Project 4: Targeting EGFR and GPCR Signaling in SCCHN

Jill Siegfried, PhD, Jennifer R. Grandis, MD

Cores:

Administrative Core: Jennifer R. Grandis, MD, Eugene N. Myers, MD

Histology/Tissue Banking Core: Jennifer L. Hunt, MD, Jonas T. Johnson, MD

Biostatistics Core: Harry S. Wieand, PhD, William W. Gooding, MS, John R. Gilbertson, MD

Programs:

Career Development Program: Theresa L. Whiteside, PhD, Eugene N. Myers, MD

Developmental Research Program: William L. Bigbee, PhD, Susanne M. Gollin, PhD, Jonas T. Johnson, MD